Header Logo

Connection

CARL ALLEN to Melphalan

Back to Details
This is a "connection" page, showing publications CARL ALLEN has written about Melphalan.
CARL ALLEN
Connection Strength
0.209
Melphalan
  1. Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies. Blood. 2018 09 27; 132(13):1438-1451.
    View in: PubMed
    Score: 0.155
  2. Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT. Blood Adv. 2023 07 25; 7(14):3725-3734.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.